Peripheral neuropathy in patients with multiple sclerosis

PLoS One. 2018 Mar 7;13(3):e0193270. doi: 10.1371/journal.pone.0193270. eCollection 2018.

Abstract

Objectives: To determine the prevalence and severity of neuropathic pain, sudomotor dysfunction and abnormal vibration perception in patients with MS.

Methods: 73 patients with MS and 32 age-matched healthy controls underwent assessment of expanded disability severity score (EDSS), DN4 to assess neuropathic pain, electrochemical skin conductance (ESC) to assess sudomotor function and vibration perception threshold (VPT).

Results: Patients with MS had a higher DN4 score (p < 0.001) with 14% fulfilling the criteria for neuropathic pain elevated VPT (p < 0.001) and lower ESC on the feet (p < 0.001) and hands (p < 0.001) compared to control participants. ESC on the feet (32% of MS patients) and hands (30% of MS patients) were lower, and DN4 (77% of MS patients) and VPT (64% of MS patients) were greater than 2SD of the healthy control values, respectively. EDSS correlated with the number of relapses (r = 0.564, p < 0.001), VPT (r = -0.457, < 0.001) and ESC on the feet (r = -0.268, p = 0.023).

Conclusions: Patients with multiple sclerosis have evidence of sudomotor dysfunction and elevated vibration perception, which were associated with neurological disability from MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Disability Evaluation
  • Female
  • Galvanic Skin Response
  • Humans
  • Male
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / epidemiology*
  • Multiple Sclerosis / physiopathology*
  • Neuralgia / complications
  • Neuralgia / epidemiology
  • Neuralgia / physiopathology
  • Peripheral Nervous System Diseases / complications
  • Peripheral Nervous System Diseases / epidemiology*
  • Peripheral Nervous System Diseases / physiopathology*
  • Prevalence
  • Sensory Thresholds
  • Severity of Illness Index
  • Vibration

Associated data

  • figshare/9a7938564b35bd9b4cb6

Grants and funding

This work was supported by Qatar Foundation-BMRP 20038654 and Multiple Sclerosis Innovation 2016-201701.10249.POT to Dr Rayaz A Malik.